Document Type
Article
Publication Date
2004
ISSN
1741-5756
Publisher
IMS Health
Language
en-US
Abstract
The US is using free trade agreements to address the global free rider problem in pharmaceutical R&D. This brief article outlines several objections to that approach.
Recommended Citation
Kevin Outterson,
Free Trade Against Free Riders?
,
in
9
Pharma Pricing & Reimbursement
254
(2004).
Available at:
https://scholarship.law.bu.edu/faculty_scholarship/1742
